Status:
COMPLETED
Funguria in Hospitalized Patients
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Candidiasis
Eligibility:
All Genders
Up to 99 years
Brief Summary
The purpose of the study is to test the hypothesis that a subpopulation of patients with candiduria are at significant risk for disseminated disease and would benefit from treatment, while others are ...
Detailed Description
This protocol will attempt to generate a detailed clinical profile of patients with funguria and identify subgroups of patients with funguria at high risk for candiduria and determine the relative ris...
Eligibility Criteria
Inclusion
- Subjects with fungi isolated from the urine of any colony count.
- Patients seen at either Harbor-UCLA Medical Center or Cedars Sinai Medical Center.
Exclusion
- 1\. Persons with a previously positive urine fungal culture during the current hospital admission.
Key Trial Info
Start Date :
September 17 2001
Trial Type :
OBSERVATIONAL
End Date :
December 8 2008
Estimated Enrollment :
926 Patients enrolled
Trial Details
Trial ID
NCT00138502
Start Date
September 17 2001
End Date
December 8 2008
Last Update
February 4 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars Sinai Medical Center
Los Angeles, California, United States, 90048
2
UCLA Center For Vaccine Research
Torrance, California, United States, 90509